MyFinsight
Home
About
Contact
Back
Income Statement
PharmaCyte Biotech, Inc. (PMCB)
source: myfinsight.com
Download
Download image
Net income (loss)
attributable to common...
-$8,360,096
(-140.61%↓ Y/Y)
Net income (loss)
-$8,360,096
(-135.69%↓ Y/Y)
Total other income
(loss), net
-$7,511,791
(-130.42%↓ Y/Y)
Loss from operations
-$848,305
(33.15%↑ Y/Y)
Change in fair value of
convertible note receivable...
$912,000
(272.24%↑ Y/Y)
Change in fair value of
warrant liabilities
$243,000
(-88.34%↓ Y/Y)
Gain on legal
settlement - re-fair value...
$106,000
Interest income
$217,793
(-60.22%↓ Y/Y)
Change in fair value of
investment - tnf
-$2,839,000
(-491.98%↓ Y/Y)
Change in fair value of
warrant asset - femasys
-$1,215,000
(19.54%↑ Y/Y)
Change in fair value of
warrants - tnf
-$4,832,000
Total operating
expenses
$848,305
(-33.15%↓ Y/Y)
Unrealized loss on
marketable securities
-$104,463
Other expense
-$121
(36.32%↑ Y/Y)
General and
administrative
$753,148
(458.59%↑ Y/Y)
Research and development
costs
$95,157
(-0.89%↓ Y/Y)
Back